Fingerprint
Dive into the research topics of 'A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically